Epic Update : Aurobindo Pharma

Aurobindo Pharma has received final approvals from the US Food & Drug Administration (USFDA) to manufacture and market Tamsulosin Hydrochloride Capsules USP 0.4mg (ANDA 202433) and Clindamycin Palmitate Hydrochloride for Oral Solution USP (Pediatric), 75mg (base)/5mL (ANDA 202409). The products will be launched soon.

Get Free MCX Tips, Stock Tips, Forex Tips & NCDEX Tips,Commodity Tips, Share Tips, commodity tips free trial, nifty free tips, commodity trading tips, shares tips, Share Market Tips, Stock Market Tips, free stock tips on mobile, Stock trading tips, Intraday Tips.